1 – 10 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
(
- Contribution to journal › Article
- 2021
-
Mark
Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion
(
- Contribution to journal › Article
-
Mark
Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
WNT5A-induced activation of the protein kinase C substrate MARCKS is required for melanoma cell invasion
(
- Contribution to journal › Article
- 2019
-
Mark
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
(
- Contribution to journal › Article
-
Mark
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
(
- Contribution to journal › Article
- 2018
-
Mark
WNT5A as a therapeutic target in breast cancer
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article
-
Mark
Optimization, validation, and identification of two reliable antibodies for immunodetection of WNT5A
(
- Contribution to journal › Article